CARBIDOPA AND LEVODOPA
Active substance: CARBIDOPA, LEVODOPA
TABLET, ORALLY DISINTEGRATING · CARBIDOPA 25 mg/1, LEVODOPA 250 mg/1
United StatesActive
Marketing holder: Sun Pharmaceutical Industries, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- CARBIDOPA · 25 mg/1
- LEVODOPA · 250 mg/1
Registration
- Registration number
- 47335-188
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 47335-188 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 47335-188 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 47335-188 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 47335-188 · Verified 2026-10-09 · open in source